Skip to main content
. 2021 Dec 30;11(1):84. doi: 10.3390/antiox11010084

Figure 3.

Figure 3

Plasma TMAO was correlated to systolic blood pressure and SLE disease activity. (A) Plasma TMA and TMAO levels in control (CTR), CTR-group treated with 3,3-dimethyl-1-butanol (DMB) (CTR-DMB), IMQ, and IMQ-group treated with DMB (IMQ-DMB). The data are represented as means ±SEM. One-way ANOVA and Tukey’s multiple comparison test were performed. ** p < 0.01 when compared to CTR; # p < 0.05 when compared to IMQ. (B) Pearson correlation between plasma TMAO and SBP or anti-ds-DNA activity using data from all experimental groups.